Retail & Wholesale » Retail | Kingworld Medicines Group Ltd.

Kingworld Medicines Group Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
140
393
283
360
333
202
Total Accounts Receivable
457
494
295
427
429
429
Inventories
51
88
113
142
179
208
Other Current Assets
21
28
29
61
66
46
Total Current Assets
669
1,002
720
991
1,007
885
Net Property, Plant & Equipment
102
100
108
130
180
172
Total Investments and Advances
163
172
215
224
210
250
Intangible Assets
-
-
247
210
203
171
Total Assets
935
1,274
1,291
1,555
1,599
1,479
ST Debt & Current Portion LT Debt
126
295
205
475
496
Accounts Payable
156
196
139
265
152
Income Tax Payable
13
16
20
17
12
Other Current Liabilities
41
36
70
53
139
Total Current Liabilities
337
544
435
811
798
Long-Term Debt
-
123
113
7
-
Deferred Taxes
12
13
36
31
31
Total Liabilities
349
679
584
849
829
Common Equity (Total)
586
595
593
577
664
Total Shareholders' Equity
586
595
593
577
664
Total Equity
586
595
707
706
770
Liabilities & Shareholders' Equity
935
1,274
1,291
1,555
1,599
Accumulated Minority Interest
-
-
114
128
106

About Kingworld Medicines Group

View Profile
Address
8th-9th Floor, Block A
Shenzhen Guangdong 518016
China
Employees -
Website http://www.kingworld.com.cn
Updated 07/08/2019
Kingworld Medicines Group Ltd. is an investment company, which engages in the distribution of imported branded pharmaceutical and healthcare products. It operates through the Distribution Sales of Pharmaceutical and Healthcare Products; and Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices. The Distribution Sales of Pharmaceutical and Healthcare Products segment distributes and sells branded imported pharmaceutical and healthcare products primarily in Hong Kong and the People's Republic of China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.